Organovo Holdings, Inc.(NASDAQ : ONVO)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|REGN||Regeneron Pharmaceuticals, Inc.||-0.99%||724.65||2.6%||$747.27m|
|GILD||Gilead Sciences, Inc.||-0.58%||64.58||1.0%||$546.92m|
|VRTX||Vertex Pharmaceuticals, Inc.||-1.25%||294.90||1.9%||$424.55m|
|SNSS||Sunesis Pharmaceuticals, Inc.||1.99%||4.10||0.7%||$286.61m|
|SAVA||Cassava Sciences, Inc.||-4.39%||40.49||0.0%||$181.35m|
|BMRN||BioMarin Pharmaceutical, Inc.||-3.45%||88.32||4.2%||$92.61m|
|PRTA||Prothena Corp. Plc||-2.66%||57.01||13.8%||$77.10m|
|CRSP||CRISPR Therapeutics AG||-4.09%||62.59||0.6%||$75.02m|
Organovo Holdings, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.